Têxtil Renauxview S.A. (BVMF:TXRX4)
Brazil · Delayed Price · Currency is BRL 1.650
0.00 (0.00%)
Sep 2, 2026, 9:31 PM GMT-3
Têxtil Renauxview Income Statement
Financials in millions BRL. Fiscal year is January - December.
Millions BRL. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 114.83 | 115.88 | 117.68 | 132.71 | 212.42 | 162.08 | |
Revenue Growth | 0.62% | -1.53% | -11.32% | -37.52% | 31.06% | 94.03% |
Cost of Revenue | 93.63 | 91.32 | 95.46 | 113.7 | 147.46 | 106.2 |
Gross Profit | 21.21 | 24.56 | 22.22 | 19.01 | 64.96 | 55.88 |
Selling, General & Admin | 33.55 | 31.52 | 26.92 | 29.69 | 33.56 | 26 |
Other Operating Expenses | -0 | 2.6 | -0.19 | -0.09 | -0.62 | -1.05 |
Operating Expenses | 33.55 | 34.11 | 26.73 | 29.6 | 32.95 | 24.96 |
Operating Income | -12.34 | -9.55 | -4.51 | -10.59 | 32.02 | 30.93 |
Interest Expense | -28.9 | -24.95 | -22.92 | -31.58 | -32.3 | -54.8 |
Interest & Investment Income | 0.1 | 0.11 | 0.04 | 0.87 | 1.42 | 0.12 |
Currency Exchange Gain (Loss) | 0.29 | 0.96 | -1.52 | - | - | 0.03 |
Other Non Operating Income (Expenses) | -26.03 | -23.66 | -21.18 | - | - | -0.67 |
EBT Excluding Unusual Items | -66.88 | -57.09 | -50.07 | -41.29 | 1.13 | -24.4 |
Gain (Loss) on Sale of Assets | 0.04 | 0.02 | 0.71 | 0.02 | 0.05 | 0.01 |
Legal Settlements | - | - | - | - | - | 2.39 |
Other Unusual Items | 0.14 | 0.13 | 9.9 | 58.06 | -0.01 | 0.26 |
Pretax Income | -66.7 | -56.95 | -39.46 | 16.79 | 1.17 | -21.75 |
Income Tax Expense | 0.02 | 0.15 | -0.02 | 0.05 | 0.05 | 0.05 |
Net Income | -66.72 | -57.09 | -39.45 | 16.75 | 1.12 | -21.79 |
Net Income to Common | -66.72 | -57.09 | -39.45 | 16.75 | 1.12 | -21.79 |
Net Income Growth | - | - | - | 1391.10% | - | - |
Shares Outstanding (Basic) | 4 | 4 | 4 | 4 | 4 | 4 |
Shares Outstanding (Diluted) | 4 | 4 | 4 | 4 | 4 | 4 |
Shares Change | - | - | - | - | - | - |
EPS (Basic) | -15.67 | -13.41 | -9.26 | 3.93 | 0.26 | -5.12 |
EPS (Diluted) | -15.67 | -13.41 | -9.26 | 3.93 | 0.26 | -5.12 |
EPS Growth | - | - | - | 1391.10% | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 18.47% | 21.19% | 18.88% | 14.33% | 30.58% | 34.48% |
Operating Margin | -10.75% | -8.24% | -3.83% | -7.98% | 15.07% | 19.08% |
Profit Margin | -58.10% | -49.27% | -33.52% | 12.62% | 0.53% | -13.44% |
EBITDA | -8.22 | -5.37 | 0.17 | -8 | 36.97 | 35.86 |
EBITDA Margin | -7.16% | -4.63% | 0.15% | -6.03% | 17.41% | 22.13% |
D&A For EBITDA | 4.12 | 4.19 | 4.68 | 2.59 | 4.96 | 4.93 |
EBIT | -12.34 | -9.55 | -4.51 | -10.59 | 32.02 | 30.93 |
EBIT Margin | -10.75% | -8.24% | -3.83% | -7.98% | 15.07% | 19.08% |
Effective Tax Rate | - | - | - | 0.27% | 3.85% | - |